These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3535049)

  • 41. Pivmecillinam in the treatment of post-operative bacteriuria in gynecological patients. A double-blind comparison with pivmecillinam and pivampicillin.
    Aaraas I; Skarsten KW; Neess HC
    J Antimicrob Chemother; 1977 May; 3(3):227-32. PubMed ID: 326749
    [No Abstract]   [Full Text] [Related]  

  • 42. A comparative randomized double-blind clinical trial of pivampicillin and ampicillin in lower respiratory tract infections.
    Dewan J; Malik SK; Jindal SK; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):85-7. PubMed ID: 7037662
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Miraxid not a first choice agent in acute pyelonephritis].
    Sandberg T
    Lakartidningen; 1991 Feb; 88(8):608-9. PubMed ID: 1848337
    [No Abstract]   [Full Text] [Related]  

  • 44. A multicentre general practice study comparing pivampicillin (Pondocillin) and amoxycillin (Amoxil) in respiratory tract infections.
    Moran DG
    J Int Med Res; 1983; 11(6):370-4. PubMed ID: 6360752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparative study of the chemotherapeutic effectiveness of mecillinam, ampicillin and their combination in coli bacillary pyelonephritis in rats].
    Zinchenko TA; Starkov MV; Rudzit EA; Lisitsa LI
    Antibiot Med Biotekhnol; 1986 Jan; 31(1):40-3. PubMed ID: 3511839
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of the side-effects of amoxycillin and pivampicillin.
    Neringer R; Strömberg A
    Scand J Infect Dis; 1980; 12(2):133-5. PubMed ID: 6990474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ampicillin plus mecillinam vs. cefotaxime/cefadroxil treatment of patients with severe pneumonia or pyelonephritis: a double-blind multicentre study evaluated by intention-to-treat analysis.
    Cronberg S; Banke S; Bruno AM; Carlsson M; Elmrud H; Elowsson S; Josefsson K; Lindholm AC; Montelius H; Neringer R
    Scand J Infect Dis; 1995; 27(5):463-8. PubMed ID: 8588136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ampicillin and pivampicillin in the treatment of urinary tract infection in children.
    Moe OJ; Meberg A; Eng J
    Scand J Infect Dis; 1977; 9(1):31-6. PubMed ID: 320654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparative trial of pivmecillinam and ampicillin in bacteriuria of pregnancy.
    Bint A; Bullock D; Reeves D; Wilkinson P
    Infection; 1979; 7(6):290-3. PubMed ID: 232697
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Norfloxacin vs. pivmecillinam in the treatment of uncomplicated lower urinary tract infections in hospitalized elderly patients.
    Jonsson M; Englund G; Nörgård K
    Scand J Infect Dis; 1990; 22(3):339-44. PubMed ID: 2196670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparative study of amoxycillin and pivampicillin in persistent Haemophilus influenzae infection of the lower respiratory tract in children with chronic lung disease.
    Pedersen M; Støvring S; Mørkassel E; Koch C; Høiby N
    Scand J Infect Dis; 1986; 18(3):245-54. PubMed ID: 3526532
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pivmecillinam in long-term prophylaxis to girls with recurrent urinary tract infection.
    Jodal U; Larsson P; Hansson S; Bauer CA
    Scand J Infect Dis; 1989; 21(3):299-302. PubMed ID: 2756342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of pivmecillinam.
    Parsons RL; Hossack GA; Paddock GM
    Br J Clin Pharmacol; 1977 Jun; 4(3):267-73. PubMed ID: 197981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tolerance of two ampicillin esters: a comparison of pivampicillin and bacampicillin.
    Hjort N; Renmarker K; Rosberg B; Skog PA; Hey H
    Pharmatherapeutica; 1983; 3(6):398-404. PubMed ID: 6353431
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative efficacies of pivmecillinam and ampicillin in acute shigellosis.
    Kabir I; Rahaman MM; Ahmed SM; Akhter SQ; Butler T
    Antimicrob Agents Chemother; 1984 May; 25(5):643-5. PubMed ID: 6329092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Successful treatment of ctx-m ESBL producing Escherichia coli relapsing pyelonephritis with long term pivmecillinam.
    Nicolle LE; Mulvey MR
    Scand J Infect Dis; 2007; 39(8):748-9. PubMed ID: 17654359
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In-vitro sensitivity of organisms causing urinary tract infections to four common oral antibiotics and to pivmecillinam.
    Bansal AS
    West Indian Med J; 1988 Dec; 37(4):201-4. PubMed ID: 3266047
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical studies on the tolerance of a new antibiotic combination, pivampicillin and dicloxacillin].
    Fiori GP
    Arch Sci Med (Torino); 1976; 133(2):127-34. PubMed ID: 795400
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An open study of pivampicillin (Pondocillin) as a treatment for acute lower urinary tract infection.
    Sutton JB
    J Int Med Res; 1983; 11(6):375-9. PubMed ID: 6653869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nalidixic acid and pivmecillinam for treatment of acute lower urinary tract infections.
    Hovelius B; Mårdh PA; Nygaard-Pedersen L; Wathne B
    Scand J Prim Health Care; 1985 Nov; 3(4):227-32. PubMed ID: 4081404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.